Direct answer: An OEM sign-off should identify the exact formula, raw-material form, package, label version and destination market. A new peptide source, pouch or claim can reopen testing and artwork approval even when the product name stays the same.
Editorial review: 31 October 2026. Verify current market rules and batch-specific evidence before procurement.
What belongs in a usable approval packet?
Keep one versioned packet for the approved product: formula and ingredient source, bill of materials, measurable finished-product specification, artwork, primary pack and target market. The product name alone cannot distinguish a change in peptide salt form, carrier, preservative or fill. Link each sample to its formula revision and each proof to the corresponding packaging dieline. For a cosmetic project, the buyer should identify the party that will substantiate finished-product safety and approve claims. FDA describes the responsible person for US cosmetics as the manufacturer, packer or distributor whose name appears on the label, subject to the applicable statutory provisions. Supplier data feed that review but do not replace it. Record who signs technical, regulatory, brand and commercial approvals; then state whether a change after sign-off needs new samples, stability work or documentation. The private-label service page is an introduction, while the signed packet governs a real order.
Approval packet
- Formula and ingredient identity revision
- Finished specification and test methods
- Primary pack and artwork revision
- Named approvers and destination markets
When does an apparently small change need fresh evidence?
A new pouch supplier may change barrier performance, while an altered film size can change content per unit. A revised peptide raw material can have a different impurity profile even if the marketing name is unchanged. Treat the proposed change as a question about impacted attributes: identity, stability, microbiological controls where relevant, packaging integrity and the accuracy of label text. ICH Q10 describes a formal change-management system for pharmaceutical quality systems, including evaluation of the change and confirmation after implementation. It does not automatically apply to a cosmetic OEM order, but its discipline provides a useful way to frame a documented review. Log the reason, affected lots, proposed verification, required approvers and effective date. If a batch is already underway, agree its disposition before substituting material or artwork. A revision history gives the buyer a way to trace which product a later complaint or document actually describes.
Change record
- Changed component or statement and reason
- Affected formula, lots, orders and markets
- Evidence needed before release
- Approval and implementation dates
How should a US cosmetic label be checked?
FDA’s cosmetic labeling guidance identifies several information categories that need review, including product identity and net quantity on the principal display panel, and the name and place of business plus ingredient declaration on an information panel when applicable. The exact requirements depend on the product and how it is sold. Do not copy a competitor’s label or assume that a supplier’s carton mockup is a regulatory approval. FDA also says claims must be truthful and that claims to treat disease or affect body structure or function can move a product into drug regulation. An OEM artwork check therefore needs the intended market, complete formula, package dimensions, warnings or directions where needed, and a record of claim substantiation. Print and digital sales copy should be reviewed together, because website language may establish intended use. Lock the approved version before printing and retain a final physical proof. The project inquiry form can capture market and packaging requirements at the start.
Artwork checks
- Product identity and net quantity
- Responsible company and ingredient declaration
- Required caution or use information
- Claims across carton, leaflet and website
Frequently asked questions
Can an artwork edit be made after formula approval?
Yes, but it should be versioned and checked against the approved formula, pack and destination-market requirements before printing.
Does a supplier sample approve a finished cosmetic claim?
No. The responsible business must assess the actual finished product and substantiate its claims for the intended market.
Should a new packaging supplier trigger review?
Yes. Evaluate the new component's fit, protection, seal and label implications for the approved product.
References and scope
Sources below support the specific technical and regulatory points cited above. Studies describe their tested materials, not this supplier’s batches. ICH guidelines are cited within their stated pharmaceutical scope; project requirements need separate review.
- FDA summary of US cosmetic labeling requirements
- FDA cosmetic labeling claims
- ICH Q10 pharmaceutical quality system
Related: resource library · product catalog · quality and documentation · request a quote.